Development and Implementation of a Continuing Medical Education Program in Canada: Knowledge Translation for Renal Cell Carcinoma (KT4RCC).


Journal

Journal of cancer education : the official journal of the American Association for Cancer Education
ISSN: 1543-0154
Titre abrégé: J Cancer Educ
Pays: England
ID NLM: 8610343

Informations de publication

Date de publication:
02 2019
Historique:
pubmed: 6 8 2017
medline: 13 2 2020
entrez: 6 8 2017
Statut: ppublish

Résumé

An in-person multidisciplinary continuing medical education (CME) program was designed to address previously identified knowledge gaps regarding quality indicators of care in kidney cancer. The objective of this study was to develop a CME program and determine if the program was effective for improving participant knowledge. CME programs for clinicians were delivered by local experts (uro-oncologist and medical oncologist) in four Canadian cities. Participants completed knowledge assessment tests pre-CME, immediately post-CME, and 3-month post-CME. Test questions were related to topics covered in the CME program including prognostic factors for advanced disease, surgery for advanced disease, indications for hereditary screening, systemic therapy, and management of small renal masses. Fifty-two participants attended the CME program and completed the pre- and immediate post-CME tests. Participants attended in Ottawa (14; 27%), Toronto (13; 25%), Québec City (18; 35%), and Montréal (7; 13%) and were staff urologists (21; 40%), staff medical oncologists (9; 17%), fellows (5; 10%), residents (16; 31%), and oncology nurses (1; 2%). The mean pre-CME test score was 61% and the mean post-CME test score was 70% (p = 0.003). Twenty-one participants (40%) completed the 3-month post-CME test. Of those that completed the post-test, scores remained 10% higher than the pre-test (p value 0.01). Variability in test scores was observed across sites and between French and English test versions. Urologists had the largest specialty-specific increase in knowledge at 13.8% (SD 24.2, p value 0.02). The kidney cancer CME program was moderately effective in improving provider knowledge regarding quality indicators of kidney cancer care. These findings support continued use of this CME program at other sites.

Identifiants

pubmed: 28779441
doi: 10.1007/s13187-017-1259-7
pii: 10.1007/s13187-017-1259-7
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-18

Références

Milbank Q. 1998;76(4):517-63, 509
pubmed: 9879302
Med Care. 2001 Aug;39(8 Suppl 2):II46-54
pubmed: 11583121
J Contin Educ Health Prof. 2007 Winter;27(1):6-15
pubmed: 17385735
BMJ. 1999 May 8;318(7193):1276-9
pubmed: 10231265
J Oncol Pract. 2013 Sep;9(5):e262-7
pubmed: 23943895

Auteurs

Luke T Lavallée (LT)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.
University of Ottawa, Ottawa, Canada.

Ryan Fitzpatrick (R)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
University of Ottawa, Ottawa, Canada.

Lori A Wood (LA)

QEII Health Sciences Centre, Halifax, Canada.
Dalhousie University, Halifax, Canada.

Joan Basiuk (J)

University Health Network, Toronto, Canada.

Christopher Knee (C)

Ottawa Hospital Research Institute, Ottawa, Canada.

Sonya Cnossen (S)

Ottawa Hospital Research Institute, Ottawa, Canada.

Ranjeeta Mallick (R)

Ottawa Hospital Research Institute, Ottawa, Canada.

Kelsey Witiuk (K)

Ottawa Hospital Research Institute, Ottawa, Canada.

Marie Vanhuyse (M)

McGill University, Montreal, Canada.

Simon Tanguay (S)

McGill University, Montreal, Canada.

Antonio Finelli (A)

University Health Network, Toronto, Canada.
Princess Margaret Cancer Centre, Toronto, Canada.
University of Toronto, Toronto, Canada.

Michael A S Jewett (MAS)

University of Toronto, Toronto, Canada.

Naveen Basappa (N)

Cross Cancer Institute, Edmonton, Canada.
University of Alberta, Edmonton, Canada.

Jean-Baptiste Lattouf (JB)

Centre hospitalier de l'Université de Montréal, Montreal, Canada.
Université de Montréal, Montreal, Canada.

Geoffrey T Gotto (GT)

University of Calgary, Calgary, Canada.

Sohaib Al-Asaaed (S)

Memorial University, St. John's, Canada.

Georg A Bjarnason (GA)

Sunnybrook Odette Cancer Centre, Toronto, Canada.

Ronald Moore (R)

Cross Cancer Institute, Edmonton, Canada.
University of Alberta, Edmonton, Canada.

Scott North (S)

Cross Cancer Institute, Edmonton, Canada.
University of Alberta, Edmonton, Canada.

Christina Canil (C)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
Ottawa Hospital Research Institute, Ottawa, Canada.
University of Ottawa, Ottawa, Canada.

Frédéric Pouliot (F)

Université Laval, Quebec City, Canada.

Denis Soulières (D)

Centre hospitalier de l'Université de Montréal, Montreal, Canada.

Vincent Castonguay (V)

Centre Hospitalier Universitaire de Québec, Quebec City, Canada.

Wassim Kassouf (W)

McGill University, Montreal, Canada.

Ilias Cagiannos (I)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
University of Ottawa, Ottawa, Canada.

Chris Morash (C)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada.
University of Ottawa, Ottawa, Canada.

Rodney H Breau (RH)

Division of Urology, Department of Surgery, The Ottawa Hospital, 501 Smyth Rd, Ottawa, ON, K1H 8L6, Canada. rbreau@toh.ca.
Ottawa Hospital Research Institute, Ottawa, Canada. rbreau@toh.ca.
University of Ottawa, Ottawa, Canada. rbreau@toh.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH